OncoCyte Investor Relations Material
Latest events
Q4 2024
OncoCyte
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from OncoCyte Corporation
Access all reports
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. Its tests apply genetic analysis technology to advance early detection of cancer. The company's lead product candidates are Circulating Tumor Cell (CTC), a blood test to detect lung cancer; and DetermaIO, a bioinformatic analysis software that provides interpretative information on the outputs from various types of assays, including CTC. It is also developing DetermaVu, a cell free DNA blood test for detecting various types of lung cancer; DetermaSolver, a proprietary technology.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
OCX
Country
🇺🇸 United States